Hemostasis and Coagulation

Slides:



Advertisements
Similar presentations
The Basics of Hemophilia
Advertisements

Basic coagulation techniques and Quality control issues
Coagulation: Review & Lab techniques
Chapter 12 Disorders of Hemostasis
J. Bormanis/ cg edits  When did it start ?  Dental history  Spontanous bruising  Bleeding at surgery  Bleeding into joints  Menstrual bleeding.
Initiation substances activate s by proteolysis a cascade of circulating precursor proteins which leads to the generation of thrombin which in turn converts.
Tests of Hemostasis Path 430/826 David Lillicrap Department of Pathology and Molecular Medicine Queen’s University, Kingston, Canada.
Bachelor of Chinese Medicine, The University of Hong Kong Bleeding disorders Dr. Edmond S. K. Ma Division of Haematology Department of Pathology The University.
Haemostasis Tiffany Shaw MBChB II Haemostasis Pathway Injury Collagen exposure Tissue Factor Platelet adhesion Coagulation Cascade Release reaction.
Gatmaitan, Raymond Vincent Golpeo, Kirsten C.
Bleeding time,clotting time, PT, and PTT
Dr msaiem Acquired Coagulation Disorders Dr Mohammed Saiem Al-dahr KAAU Faculty of Applied Medical Sciences.
Week 6: Secondary Hemostasis Plasmatic factors Plasmatic factors Intrinsic pathway Intrinsic pathway Extrinsic pathway Extrinsic pathway Specimen Specimen.
Interactive Session on Clotting Profile Dr P T R Makuloluwa MBBS (Col), MD (Anaesthesiology), FRCA (Lond)
Lecture NO- 12- Dr: Dalia Kamal Eldien.  Coagulation: Is the process by which blood changes from a liquid to a clot. Coagulation begins after an injury.
Bleeding time,clotting time, PT, and PTT
This lecture was conducted during the Nephrology Unit Grand Ground by a Sub-intern under Nephrology Division, Department of Medicine in King Saud University.
Bleeding time,clotting time, PT, and PTT
Tabuk University Faculty of Applied Medical Sciences Department Of Medical Lab. Technology 3 rd Year – Level 5 – AY
Hemostasis and Blood Coagulation
Bleeding Disorders Dr. Farjah H.AlGahtani
Approach to Bleeding Disorders
Scheme of Coagulation F XIIF XIIa F XIF XIa F IX F X F IXa F VIIaF VII Extrinsic System Tissue damage Release of tissue thromboplastine (F III) Intrinsic.
1 HAEMOSTASIS. 2 Definition Haemostasis is a complex sequence of physical and biochemical changes induced by damage to tissues and blood vessels, which.
APPROACH TO BLEEDING DISORDERS. History of Bleeding Spontaneous vs. trauma/surgery-induced Ecchymoses without known trauma Medications or nutritional.
Coagulation Concepts A review of hemostasis Answers are in the notes pages.
Coagulation Mechanisms
Disseminated Intravascular Coagulation. XIIa Coagulation cascade IIa Intrinsic system (surface contact ) XII XI XIa Tissue factor IX IXa VIIa VII VIIIVIIIa.
BLEEDING DISORDERS LCDR ART GEORGE.
1 Bleeding disorders K. Bernášková. 2 The Hemostatic System.
Investigation of Haemostasis MS. c. program Lab-9.
Bleeding and Kristine Krafts, M.D. Thrombotic Disorders.
Inherited bleeding disorder of primary hemostasis.
Hematology Blueprint PANCE Blueprint. Coagulation Disorders.
Tests of Hemostasis Path 430/826 David Lillicrap Department of Pathology and Molecular Medicine Queen’s University, Kingston, Canada.
Intrinsic pathway Extrinsic pathway Common pathway The extrinsic pathway was required the addition of an exogenous trigger (originally provided by tissue.
Hemostasis and Coagulation Hemostasis Hemostasis is the maintenance of circulating blood in the liquid state and retention of blood in the vascular system.
Haemostasis. Indications for hemostasis test – Identify patients presenting with bleeding that have a correctable bleeding tendency – Identify patients.
1. Normal haemostasis Haemostasis is the process whereby haemorrhage following vascular injury is arrested. It depends on closely linked interaction.
Hemostasis Is a complex process which causes the bleeding process to stop. It refers to the process of keeping blood within a damaged blood vessel. Dependent.
Approach to the Bleeding Child. Evaluation  History Current Bleeding Medical Family  Physical exam  Selected laboratory investigations.
Coagulation tests CBC- complete blood count
Bleeding Tendency Dr. Mervat Khorshied Ass. Prof. of Clinical and Chemical Pathology.
Platelets. Fig Hemostasis the process by which the bleeding is stopped from broken vessels. steps involved: Vascular spasm. Platelets plug formation.
Haemostasis describes the normal process of blood clotting. It takes place via a series of complex, tightly regulated interactions involving cellular.
Congenital bleeding disorders
Multiple choice questions
These factors prevent blood clotting - in normal state.
Haematology.
General Approach of Haemostasis
General Principles of Hemostasis Kristine Krafts, M.D.
Bleeding disorders Dr. Feras FARARJEH.
General Approach in Investigation of Hemostasis
Hypercoagulable States
Platelets disorders.
Diagnosis Approach of Bleeding in Children ________________________________ Ketut Ariawati Hematologi Onkologi RSUP Sanglah Denpasar.
Constituents of the blood: Platelets and plasma
Hemostasis.
Hemodynamic disorders (1 of 3)
and anti-thrombotic pharmocology Tom Williams
Coagulation Cascade of the Newborn
Dr-Majid Qanavat Ped. Hematologist oncologist Isfahan university -1396
platelet function:    1- Adhesion — the deposition of platelets on the .
The Fascinating World of Haemostasis and Thrombosis
Intrinsic pathway Formation of prothombin activator is the central event in the clotting pathway For its formation the pathway that is initiated by.
Bleeding and Thrombotic Disorders Kristine Krafts, M.D.
Bleeding disorders Dr. Feras FARARJEH.
General Principles of Hemostasis Kristine Krafts, M.D.
Principles of Coagulation Screening II
Hemostasis Hemostasis depends on the integrity of Blood vessels
Presentation transcript:

Hemostasis and Coagulation 1

Intended Learning Outcomes (ILOs) Discuss laboratory evaluation of hemostatic function. Design a plan to diagnose a case of thrombocytopenia. Recall causes of prolonged prothrombin time (PT) Recall causes of prolonged activated partial thromboplastin time (APTT) Demonestrate laboratory profile of Von Willebrand Disease. - Interpret various cases characterized by hemostatic function defect.

Components of hemostasis Hemostasis: is the process by which bleeding is arrested after injury to blood vessels Normal hemostasis requires the interaction of platelets and clotting cascade with normal blood vessels

Balance in Hemostasis Haemostasis depends on a delicate balance between procoagulant and anticoagulant mechanisms A disruption of this unique balance may cause bleeding or thrombosis Hemostasis Anticoagulant Procoagulant Thrombosis Anticoagulant Procoagulant Bleeding Anticoagulant Procoagulant

Mechanism of coagulation Intrinsic pathway Extrinsic pathway XIIa contact factors TF XIa VIIa lXa Xa VIIIa Test: PTT Test: PT Va Ca++ finronolysis II IIa Fibrinogen Fibrin

Presentation Bleeding Tendency: Excessive bleeding (spontaneous/ after injury) Easy hematoma formation after minor trauma Recurrent epistaxis Menorrhagia Abnormal bleeding during operation , or post operative Petichae, purpuric eruption, ecchymosis Thrombosis: Deep venous thrombosis (DVT)

LABORATORY EVALUATION OF HEMOSTATIC FUNCTION Screening tests: done for all suspected patients Bleeding time Platelet count Prothombin time (PT) Partial thromboplastin time (PTT) Thrombin time (TT) Specific tests : done according to results of screening tests 7

BLEEDING TIME Time needed to stop bleeding after induced needle prick Affected by Platelet count Platelet function Vessel wall Normal range: Ivy’s method: up to 7 min Note: it is not a sensitive test for minor or even moderate abnormality. 8

Bleeding time: BT Causes of prolonged bleeding time: 1-Thrombocytopenia (moderate or severe). 2-Disorders of platelet function. *VWD *Glanzmann’s disease *Bernard Soulier syndrome 3-Vascular abnormalities

PLATELET COUNT Normal platelet count = 150-400 x109/L A part of complete blood picture (CBC) Performed by electronic counters or manually Note: Any case of unexpected very low platelet count should be rechecked particularly in infants and young children when sampling is difficult. 10

Investigation of a case of thrombocytopenia History CBC Bone Marrow ANA

QUALITATIVE PLATELET DEFECT In a case presenting with purpura and normal platelet count and other coagulation tests you have to suspect defective platelet functions. 12

Tests Morphology of platelet in smear Platelet aggregation

PROTHROMBIN TIME (PT) Test for extrinsic pathway (FVII, FII, FV, X) [majority are vitamin K dependent factor]. Used for monitoring oral anticoagulant therapy and used as a liver function test Normal range: 10-14 sec 14

Prothrombin Time PT Tissue extract ca Fibrin clot Plasma

Causes of prolonged PT Oral anticoagulants Liver disease Vit K deficiency (FII, VII , IX and X ) Congenital deficiency of factors involved in extrinsic pathway. DIC inhibitors 16

Reporting Of PT Test Example Patient : 12 sec Control : 11 sec INR : 1.1

PARTIAL THROMBOPLASTIN (PTT) It is a test for intrinsic pathway of blood coagulation (FVIII, FIX, FXI, FXII, FII, FV, X). It is the test Used for patients receiving heparin therapy Normal range: 30-40 sec 18

Causes of prolonged PTT 19

Causes of prolonged PTT Heparin Deficiency of factors involved in intrinsic pathway, usually congenital: Hemophilia A Hemophilia B and von Willebrand disease) DIC Massive transfusion (labile FV, FVIII) Inhibitors 20

BT PT PTT Platelet count Platelet function Other tests ITP Glanzman disease Bernard Soulier S Hemoph A Hemoph B vWD DIC 21

To summarize

Investigation Of Bleeding Disorder

APTT Bleeding Time (BT) Prolonged Normal Platelets Count Platelets Function Blood vessels Check PT APTT APTT Hemophilia Heparin PT Oral AC

Prothrombin Time (PT) Prolonged Oral anticoagulant Vitamin K deficiency Liver Disease DIC inhibitors

Activated Partial Thromboplastin Time (aPTT) Heparin anticoagulant Prolonged Heparin anticoagulant Hemophilia Massive Liver Disease DIC inhibitors Von Willebrand Disease

Prolonged (BT) + Prolonged APTT+ Normal PT Von Willebrand Disease Prolonged (BT) + Prolonged APTT+ Prolonged PT Massive Liver Disease DIC

Case study

bleeding time 10 min (normal, 2-7 min) Case 1 A 32-years old woman observes the presence of multiple petechiae, purpura and ecchymosis rashes when she wakes up in the morning . She had a history of epistaxis requiring cauterization. platelet count 50 x 109/L bleeding time 10 min (normal, 2-7 min) This woman might be suffering from: a-Immune thrombocytopenic purpura b-Von Willebrand disease c-Glanzmann’s disease d-a, b & c e-b & c 29

bleeding time 10 min (normal, 2-7 min) Case 2 A 19-years old woman complained of prolonged menstrual bleeding. She had a history of epistaxis requiring cauterization. platelet count 180 x 109/L bleeding time 10 min (normal, 2-7 min) This woman might be suffering from: a-immune thrombocytopenic purpura b-von Willebrand disease c-Glanzmann’s disease d- a, b & c e-b & c 30

Case 3 A 3 year old boy presents with a painful left elbow after mild trauma. Evaluation reveals a hemarthrosis. Platelets count is 190X109/L BT & PT are normal PTT is prolonged Which of the following is the most likely diagnosis? hemophilia A Von Willebrand Disease Bernard Soulier syndrome immune thrombocytopenic purpura aspirin intake

Case 4 A 30 year old man presents with easy bruising PT 13 seconds (normal, 10-14 seconds) PTT 60 seconds (normal, 30-40 seconds) BT 11 minutes (normal 2-7 minutes) Which of the following is the most likely diagnosis? hemophilia A hemophilia B von Willebrand disease immune thrombocytopenic purpura aspirin intake 32

CASE 5 A 42 year-old man brought to the emergency room with severe second- and third-degree burns. SCREENING COAGULATION LABORATORY RESULTS PT= 17 sec (Normal 8-11.5) aPTT= 49 sec (Normal 24-37.5) Platelet count= 20,000 /μL hemophilia A hemophilia B von Willebrand disease DIC Glanzmann’s disease

BT PT PTT Platelet count Platelet function Other tests ITP P N Bone marrow Glanzman disease Defect aggreg Hemoph A FVIII assay Hemoph B FIX assay vWD FVIII, vWF DIC Fibrinogen FDPs 34

THROMBOPHILIA

Group of disorders that predispose to venous thrombosis THROMBOPHILIA Heritable thrombophilia Acquired thrombophilia Group of disorders that predispose to venous thrombosis

INHERETED THROMBOPHILIA ACQUIRED THROMBOPHILIA Anti-thrombin deficiency Iatrogenic: surgery -hormonal therapy – chemo/radiotherapy – drugs Protein C deficiency Environmental: Age - obesity -pregnancy – trauma – Immobility Protein S deficiency Disease related: APS – Neoplasia – MPN – PNH – TTP – Inflammation – stroke -SCD Factor V leiden (FV R 506 Q) Prothrombin G20210A mutation MTHFR

DIAGNOSIS HEREDITARY THROMBOPHILIA Assays for: AT-III, Protein C Protein S Molecular studies for: FV leiden Prothrombin G20210A Homocysteinaemia ACQUIRED THROMBOPHILIA: Tests for APS, Lupus Anti-coagulant

Thank You